Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma
The development of immunotherapy has changed the treatment landscape of advanced kidney renal clear cell carcinoma (KIRC), offering patients more treatment options. Cuproptosis, a novel cell death mode dependent on copper ions and mitochondrial respiration has not yet been studied in KIRC. We assemb...
Main Authors: | Ganghua Zhang, Xinyu Chen, Jianing Fang, Panpan Tai, Aiyan Chen, Ke Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.954440/full |
Similar Items
-
Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
by: Gang Luo, et al.
Published: (2023-05-01) -
The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma
by: Guojie Lei, et al.
Published: (2023-11-01) -
Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
by: Aibin Liu, et al.
Published: (2022-10-01) -
The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
by: Lishuo Zhang, et al.
Published: (2023-01-01) -
Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma
by: Maoshu Zhu, et al.
Published: (2023-07-01)